Details
 

October 6, 2021
8:00-9:30PM

Breaking Up Hypnosis into Parts: A Scientific Exploration of the Multifaceted View of Hypnotic Phenomena (AGD #130)

Presenter: Mathieu Landry, Ph.D.

Delivered via Zoom - Start Time is Eastern Time

Despite long-standing efforts to unravel the underlying mechanisms of hypnotic phenomena, they mostly remain elusive to the scientific and clinical communities as evidenced by ongoing debates about the interpretation of key findings in the literature. Clearly, hypnosis is complex and does not lend itself easily to a reductionist approach, which challenges future advances.

This discussion will focus on the centrality of top-down regulation processes and their corresponding neural networks, while also emphasizing how the content of suggestions and mental imagery serve as guides towards specific outcomes. In sum, we will stress how these different components shape the emergence of hypnotic phenomena and highlight the latest relevant findings in the cognitive neuroscience of hypnosis.

Learning Objectives:

After participating in this program physicians and other mental health professionals should be able to:

CE:  This webinar is eligible for 1.5 hours of ASCH CE.

Registration Fee: $35 for ASCH Members | $45 for Non-Members of ASCH
Note:  Non-Members will select the Create a New Account option to register for this program.  

Cancellation Policy: No fees will be refunded for this webinar. 

Register Here


Speaker: 

Landry

Mathieu Landry, Ph.D.

Dr. Mathieu Landry completed his Ph.D. in cognitive neuroscience at McGill University. Broadly, his research explores how cognition (e.g., attention, anticipation, executive control) shapes consciousness (i.e., how we subjectively experience the world and our own mind). His work has primarily focused on the overlapping dynamics between attention, perception, and metacognition, while he also investigated and published several papers on hypnosis and suggestions. His research combines different methodologies and techniques, including neurophysiological recording such as electro- and magnetoencephalography, experimental strategies from the fields of psychophysics and cognitive psychology, and various analytical strategies from statistics, computational modeling, machine learning.

 

No ASCH-ERF staff or committee members involved in the development, planning, or execution of educational content have any financial relationships or conflicts of interest to disclose.

Mathieu Landry, Ph.D. has no significant financial relationships to disclose.

CME APPROVAL

This program has been approved by the American Society of Clinical Hypnosis Standards of Training Committee to be used toward Membership and Certification requirements.

 The American Society of Clinical Hypnosis-Education and Research Foundation (ASCH-ERF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 The American Society of Clinical Hypnosis-Education and Research Foundation (ASCH-ERF) designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 The American Society of Clinical Hypnosis-Education and Research Foundation (ASCH-ERF) is approved by the American Psychological Association to sponsor continuing education for psychologists. ASCH-ERF maintains responsibility for this program and its content.

 This course is approved by the American Society of Clinical Hypnosis and as such is an approved continuing education course per Florida’s AC-Rule 64B-4-6002

 

Ace

The American Society of Clinical Hypnosis Education & Research Foundation Nationally Approved PACE Program Provider for FAGD/MAGD credit. Approval does not imply acceptance by any regulatory authority or AGD endorsement.  10/1/2021 to 9/30/2027.  Provider ID#217022

Printer-Friendly Version


2021-10-06 20:00:00 2021-10-06 21:30:00 America/Detroit Breaking Up Hypnosis into Parts: A Scientific Exploration of the Multifaceted View of Hypnotic Phenomena (AGD #130) Despite long-standing efforts to unravel the underlying mechanisms of hypnotic phenomena, they mostly remain elusive to the scientific and clinical communities as evidenced by ongoing debates about the interpretation of key findings in the literature. Clearly, hypnosis is complex and does not lend itself easily to a reductionist approach, which challenges future advances. This discussion will focus on the centrality of top-down regulation processes and their corresponding neural networks, while also emphasizing how the content of suggestions and mental imagery serve as guides towards specific outcomes. In sum, we will stress how these different components shape the emergence of hypnotic phenomena and highlight the latest relevant findings in the cognitive neuroscience of hypnosis. Learning Objectives: After participating in this program physicians and other mental health professionals should be able to: Describe some of the key components of hypnosis identified by the scientific literature and explain their relative contribution to hypnotic phenomena. Describe findings in the literature that highlight the involvement of each component in the context of hypnosis. Identify and classify neuroimaging findings in light of the multifaceted view of hypnosis. Evaluate how the multifaceted view of hypnosis provides insights for helping patients produce more efficient responses in the clinical context. CE:  This webinar is eligible for 1.5 hours of ASCH CE. Registration Fee: $35 for ASCH Members | $45 for Non-Members of ASCHNote:  Non-Members will select the Create a New Account option to register for this program.   Cancellation Policy: No fees will be refunded for this webinar.  Register Here Speaker:  Mathieu Landry, Ph.D. Dr. Mathieu Landry completed his Ph.D. in cognitive neuroscience at McGill University. Broadly, his research explores how cognition (e.g., attention, anticipation, executive control) shapes consciousness (i.e., how we subjectively experience the world and our own mind). His work has primarily focused on the overlapping dynamics between attention, perception, and metacognition, while he also investigated and published several papers on hypnosis and suggestions. His research combines different methodologies and techniques, including neurophysiological recording such as electro- and magnetoencephalography, experimental strategies from the fields of psychophysics and cognitive psychology, and various analytical strategies from statistics, computational modeling, machine learning.   No ASCH-ERF staff or committee members involved in the development, planning, or execution of educational content have any financial relationships or conflicts of interest to disclose. Mathieu Landry, Ph.D. has no significant financial relationships to disclose. CME APPROVAL This program has been approved by the American Society of Clinical Hypnosis Standards of Training Committee to be used toward Membership and Certification requirements.  The American Society of Clinical Hypnosis-Education and Research Foundation (ASCH-ERF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The American Society of Clinical Hypnosis-Education and Research Foundation (ASCH-ERF) designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  The American Society of Clinical Hypnosis-Education and Research Foundation (ASCH-ERF) is approved by the American Psychological Association to sponsor continuing education for psychologists. ASCH-ERF maintains responsibility for this program and its content.  This course is approved by the American Society of Clinical Hypnosis and as such is an approved continuing education course per Florida’s AC-Rule 64B-4-6002   The American Society of Clinical Hypnosis Education & Research Foundation Nationally Approved PACE Program Provider for FAGD/MAGD credit. Approval does not imply acceptance by any regulatory authority or AGD endorsement.  10/1/2021 to 9/30/2027.  Provider ID#217022 Delivered via Zoom - Start Time is Eastern Time